Company Profile
Tactile Systems Technology, Inc. Stock Price, News & Analysis
Company overview
Business overview
Tactile Systems Technology is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Tactile Systems Technology sits inside the cell therapy universe where trial execution and regulatory timing can change the investment case quickly.
Business Model Characteristics
Tactile Systems Technology follows a platform-led model where readouts, manufacturing progress, and commercialization milestones matter as much as the initial science. The market tends to reprice the stock quickly whenever adoption, safety, or label-expansion signals improve.
Position Within the Biotechnology Landscape
Compared with larger diversified biotech peers, Tactile Systems Technology sits at the high-catalyst end of the landscape, where cell therapy names can move sharply on data, approvals, and launch milestones.
Why the stock is moving
TCMD is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Tactile Medical is still a product-therapy company at heart, with Flexitouch and its related chronic-disorder therapies doing the heavy lifting. The important thing now is whether those therapies keep building enough routine use to make the commercial base feel steadier.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Tactile Medical to Release Third Quarter of Fiscal Year 2025 Financial Results on November 3, 2025
Source: Tactile Systems Technology, Inc.
- 02
Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema
Source: Tactile Systems Technology, Inc.
- 03
Tactile Systems Technology, Inc. Reports Third Quarter 2025 Financial Results
Source: Tactile Systems Technology, Inc.
- 04
Tactile Medical to Present at the Piper Sandler 37th Annual Healthcare Conference
Source: Tactile Systems Technology, Inc.
- 05
Tactile Medical to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 17, 2026
Source: Tactile Systems Technology, Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.